Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Respiratory Distress Syndrome in Premature Infant: early-phase trial registry
1 of 2 indexed Respiratory Distress Syndrome in Premature Infant trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count
Respiratory Distress Syndrome in Premature Infant: 2 US clinical trials tracked, 1 recruiting.
Respiratory Distress Syndrome in Premature Infant is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Tufts Medical Center, running 1 of these trials.
Enrollment posture brief
Registry condition respiratory-distress-syndrome-in-premature-infant
OPEN 1 | RECR 50% | LATE 0 | EARLY 1 | RANK #7188 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
Respiratory Distress Syndrome in Premature Infant lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Respiratory Distress Syndrome in Premature Infant on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Respiratory Distress Syndrome in Premature Infant is recruiting above its size-band peers.
1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
2 total, page 1 of 1
Predicting the Need for Prolonged Respiratory Support in Neonates Delivered in a Lower-Level NICU Setting
Mayo Clinic
NCT07344714
Efficacy of Recombinant Human Clara Cell 10 Protein (rhCC10) Administered to Premature Neonates With Respiratory Distress Syndrome
Tufts Medical Center
NCT01941745
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Respiratory Distress Syndrome in Premature Infant records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Respiratory Distress Syndrome in Premature Infant trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Respiratory Distress Syndrome in Premature Infant page
2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Respiratory Distress Syndrome in Premature Infant trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Tufts Medical Center sponsors the most Respiratory Distress Syndrome in Premature Infant trials on record, review their full trial history before evaluating a specific study. See Tufts Medical Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Respiratory Distress Syndrome in Premature Infant condition card totals 2 registered trials; most-linked intervention High dose rhCC10; top US site state Minnesota. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.